Viral infections of the equine respiratory tract

Equine Respiratory Medicine and Surgery

Volumn , Issue , 2007, Pages 287-326

  Wood, James ^a   Smith, Kenneth C ^b   Daly, Janet M ^c   Newton, J Richard ^b  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b ANIMAL HEALTH TRUST   (United Kingdom)

^c ANIMAL HEALTH TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84882561595     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-7020-2759-8.50027-1     Document Type: Chapter

References (220)

1. Allen GP, Bryans JT, Pandey R Molecular epizootiology, pathogenesis, and prophylaxis of equine herpesvirus-1 infections. Veterinary microbiology molecular and clinical perspectives. Progress in Veterinary Microbiology and Immunology 1986, 2:78-144.
2. Allen G, Yeargan M, Costa LR, et al. Major histocompatibility complex class I-restricted cytotoxic T-lymphocyte responses in horses infected with equine herpesvirus 1. Journal of Virology 1995, 69:606-612.
3. Allen GP, Kydd JH, Slater JD, et al. Advances in understanding of the pathogenesis, epidemiology and immunological control of equine herpesvirus abortion. Proceedings of the Eighth International Conference on Equine Infectious Diseases, Dubai 1999, R&W Publications Ltd, Newmarket UK.
4. Anon African horse sickness. Conclusions and recommendations of a scientific meeting. Bulletin of the Office of International Epizootics 1997, 4:406-411.
5. Balasuriya UB, Timoney PJ, McCollum WH, et al. Phylogenetic analysis of open reading frame 5 of field isolates of equine arteritis virus and identification of conserved and nonconserved regions in the GL envelope glycoprotein. Virology 1995, 214:690-697.
6. Balasuriya UB, Patton JF, Rossitto PV, et al. Neutralization determinants of laboratory strains and field isolates of equine arteritis virus: identification of four neutralization sites in the amino-terminal ectodomain of the G(L) envelope glycoprotein. Virology 1997, 232:114-128.
7. Barnard BJ, Paweska JT Prevalence of antibodies against some equine viruses in zebra ( Zebra burchelli) in the Kruger National Park, 1991-1992. Onderstepoort Journal of Veterinary Research 1993, 60:175-179.
8. Baylis M, El Hasnaoui H, Bouayoune H, et al. The spatial and seasonal distribution of AHS and its potential Culicoides vectors in Morocco. Medical and Veterinary Entomology 1997, 11:203-211.
9. Baylis M, Bouayoune H, Touti J, et al. Use of climatic data and satellite imagery to model the abundance of Culicoides imicola, the vector of African horse sickness virus, in Morocco. Medical and Veterinary Entomology 1998, 12:255-266.
10. Baylis M, Touti J, Bouayoune H, et al. Studies of the mortality rate of Culicoides imicola in Morocco. Archives of Virology (Supplement) 1998, 14:127-136.
11. Baylis M, Wittman EJ, Mellor PS, et al. Prediction of areas around the Mediterranean at risk of bluetongue by modelling the distribution of its vector using satellite imaging. Veterinary Record 2001, 149:639-643.
12. Beech J Cytology of tracheobronchial aspirates in horses. Veterinary Pathology 1975, 12:157-164.
13. Blunden AS, Smith KC, Binns MM, et al. Replication of equid herpesvirus 4 in endothelial cells and synovia of a field case of viral pneumonia and synovitis in a foal. Journal of Comparative Pathology 1995, 112:133-140.
14. Borchers K, Wolfinger U, Lawrenz B, et al. Equine herpesvirus 4 DNA in trigeminal ganglia of naturally infected horses detected by direct in situ PCR. Journal of General Virology 1997, 78:1109-1114.
15. Breathnach CC, Yeargan MR, Sheoran AS, et al. The mucosal humoral immune response of the horse to infective challenge and vaccination with equine herpesvirus-1 antigens. Equine Veterinary Journal 2001, 33:651-657.
16. Browning GF, Ficorilli N, Studdert MJ Asinine herpesvirus genomes: comparison with those of the equine herpesviruses. Archives of Virology 1988, 101:183-190.
17. Bryans JT, Allen GP Application of a chemically inactivated, adjuvanted vaccine to control of abortigenic infection of mares by equine herpesvirus 1. Developments in Biological Standardization 1982, 52:493-498.
18. Bryans JT, Crowe ME, Doll ER, et al. Isolation of a filterable agent causing arteritis of horses and abortion by mares; its differentiation from the equine abortion (influenza) virus. Cornell Veterinarian 1957, 47:3-41.
19. Burrell MH, Wood JL, Whitwell KE, et al. Respiratory disease in thoroughbred horses in training: the relationships between disease and viruses, bacteria and environment. Veterinary Record 1996, 139:308-313.
20. Burrows R Equine rhinovirus and adenovirus infections. Proceedings of the 24th Annual Convention of the American Association of Equine Practitioners 1979, 299-306. St. Louis, MI.
21. Burrows R, Goodridge D, Denyer MS Trials of an inactivated equid herpesvirus I vaccine: challenge with a subtype 1 virus. Veterinary Record 1984, 114:369-374.
22. Burrows R, Goodridge D, Wittmann G Studies of persistent and latent equid herpesvirus 1 and herpesvirus 3 infections in the Pirbright pony herd. Latent Herpesvirus Infections in Veterinary Medicine. Series: Current Topics in Veterinary Medicine and Animal Science, vol 27 1984, 307-319. Martinus Nijhoff, Dordrecht. R.M. Gaskell, H.J. Rziha (Eds.).
23. Capela R, Purse BV, Pena I, et al. Spatial distribution of Culicoides species in Portugal in relation to the transmission of African horse sickness and bluetongue viruses. Medical and Veterinary Entomology 2003, 17:165-177.
24. Caracappa S, Torina A, Guercio A, et al. Identification of a novel bluetongue virus vector species of Culicoides in Sicily. Veterinary Record 2003, 153:71-74.
25. Castillo-Olivares J, de Vries AA, Raamsman MJ, et al. Evaluation of a prototype sub-unit vaccine against equine arteritis virus comprising the entire ectodomain of the virus large envelope glycoprotein (G(L)): induction of virus-neutralizing antibody and assessment of protection in ponies. Journal of General Virology 2001, 82:2425-2435.
26. Castillo-Olivares J, Tearle JP, Montesso F, et al. Detection of equine arteritis virus (EAV)-specific cytotoxic CD8+ T lymphocyte precursors from EAV-infected ponies. Journal of General Virology 2003, 84:2745-2753.
27. Castillo-Olivares J, Wieringa R, Bakonyi T, et al. Generation of a candidate live marker vaccine for equine arteritis virus by deletion of the major virus neutralization domain. Journal of Virology 2003, 77:8470-8480.
28. Chambers TM, Holland RE, Tudor LR, et al. A new modified live equine influenza virus vaccine: phenotypic stability, restricted spread and efficacy against heterologous virus challenge. Equine Veterinary Journal 2001, 33:630-636.
29. Chirnside ED, de Vries AA, Mumford JA, et al. Equine arteritis virus-neutralizing antibody in the horse is induced by a determinant on the large envelope glycoprotein GL. Journal of General Virology 1995, 76:1989-1998.
30. Christley RM, Hodgson DR, Rose RJ, et al. A case-control study of respiratory disease in Thoroughbred racehorses in Sydney, Australia. Equine Veterinary Journal 2001, 33:256-264.
31. Coetzer JAW, Erasmus B African horse sickness. Infectious Diseases of Livestock, with Special Reference to Southern Africa 1994, 460-475. Oxford University Press, Oxford. J.A.W. Coetzer, G.R. Thompson, R.C. Tutsin (Eds.).
32. Coignoul FL, Bertram TA, Cheville NF Pathogenicity of equine herpesvirus 1 subtype 2 for foals and adult pony mares. Veterinary Microbiology 1984, 9:533-542.
33. Coignoul FL, Cheville NF Pathology of maternal genital tract, placenta, and fetus in equine viral arteritis. Veterinary Pathology 1984, 21:333-340.
34. Collinson PN, O'Rielly J, Ficorilli N, et al. Isolation of equine herpesvirus type 2 (equine gammaherpesvirus 2) from foals with keratoconjunctivitis. Journal of the American Veterinary Medical Association 1994, 205:329-331.
35. Cook RF, Sinclair R, Mumford JA Detection of influenza nucleoprotein antigen in nasal secretions from horses infected with A/equine influenza (H3N8) viruses. Journal of Virological Methods 1988, 20:1-12.
36. Crabb BS, Studdert MJ Equine herpesvirus 4 (equine rhinopneumonitis virus) and 1 (equine abortion virus). Advances in Virus Research 1995, 45:153-190.
37. Crawford PC, Dubovi EJ, Castleman WL, et al. Transmission of equine influenza virus to dogs. Science 2005, 310:482-485.
38. Cullinane A, Weld J, Osborne M, et al. Field studies on equine influenza vaccination regimes in thoroughbred foals and yearlings. Veterinary Journal 2001, 161:174-185.
39. Daly JM, Lai ACK, Binns MM, et al. Antigenic and genetic evolution of equine H3N8 influenza A viruses. Journal of General Virology 1996, 77:661-671.
40. Daly JM, Yates RJ, Browse G, et al. Comparison of hamster and pony challenge models for evaluation of effect of antigenic drift on cross protection afforded by equine influenza vaccines. Equine Veterinary Journal 2003, 35:458-462.
41. Daly JM, Yates PJ, Newton JR, et al. Evidence supporting the inclusion of strains from each of the two co-circulating lineages of H3N8 equine influenza virus in vaccines. Vaccine 2004, 22:4101-4109.
42. Daly JM, Whitwell KE, Miller J et al 2006 Investigation of equine influenza cases exhibiting neurological disease: coincidence on association. Journal of Comparative Pathology (in press).
43. de la Rua-Domenech R, Reid SW, Gonzalez-Zariquiey AE, et al. Modelling the spread of a viral infection in equine populations managed in Thoroughbred racehorse training yards. Preventative Veterinary Medicine 1999, 47:61-77.
44. de Vries AA, Chirnside ED, Horzinek MC, et al. Structural proteins of equine arteritis virus. Journal of Virology 1992, 66:6294-6303.
45. Del Piero F Equine viral arteritis. Veterinary Pathology 2000, 37:287-296.
46. Del Piero F, Wilkins PA, Lopez JW, et al. Equine viral arteritis in newborn foals: clinical, pathological, serological, microbiological and immunohistochemical observations. Equine Veterinary Journal 1997, 29:178-185.
47. Dimock WW, Edwards PR The differential diagnosis of equine abortion with reference to a hitherto unknown form of epizootic abortion in mares. Cornell Veterinarian 1936, 26:231-240.
48. Ditchfield J, Zbitnew A, MacPherson LW Association of Myxovirus Para-Influenzae 3 (RE 55) with upper respiratory infection of horses. Canadian Veterinary Journal 1963, 4:175-180.
49. Doll ER, Bryans JT Incubation periods for abortion in equine viral rhinopneumonitis. Journal of Biochemistry (Tokyo) 1962, 140:351-354.
50. Doll ER, Bryans JT A planned infection program for immunizing mares against viral rhinopneumonitis. Cornell Veterinarian 1963, 53:249-262.
51. Doll ER, Bryans JT, Wilson JC, et al. Immunization against equine viral arteritis using modified live virus propagated in cell cultures of rabbit kidney. Cornell Veterinarian 1968, 48:497-524.
52. Dunowska M, Wilks CR, Studdert MJ, et al. Equine respiratory viruses in foals in New Zealand. New Zealand Veterinary Journal 2002, 50:140-147.
53. Dutta SK Isolation and characterization of an adenovirus and isolation of its adenovirus-associated virus in cell culture from foals with respiratory tract disease. American Journal of Veterinary Research 1975, 36:247-250.
54. Dutta SK, Shipley WD Immunity and the level of neutralization antibodies in foals and mares vaccinated with a modified live-virus rhinopneumonitis vaccine. American Journal of Veterinary Research 1975, 36:445-448.
55. Edington N Latency of equine herpesviruses. Proceedings of the Sixth International Conference on Equine Infectious Diseases, Cambridge 1992, 195-200. R&W Publications, Newmarket.
56. Edington N, Wright JA, Patel JR, et al. Equine adenovirus 1 isolated from cauda equina neuritis. Research in Veterinary Science 1984, 37:252-254.
57. Edington N, Bridges CG, Patel JR Endothelial cell infection and thrombosis in paralysis caused by equid herpesvirus-1: equine stroke. Archives of Virology 1986, 90:111-124.
58. Edington N, Bridges CG, Griffiths L Equine interferons following exposure to equid herpesvirus-1 or -4. Journal of Interferon Research 1989, 9:389-392.
59. Edington N, Welch HM, Griffiths L The prevalence of latent Equid herpesviruses in the tissues of 40 abattoir horses. Equine Veterinary Journal 1994, 26:140-142.
60. Edwards S, Castillo-Olivares J, Cullinane A, et al. International harmonisation of laboratory diagnostic tests for equine viral arteritis. Proceedings of the Eighth International Conference on Equine Infectious Diseases, Dubai 1999, 359-362. R&W Publications, Newmarket.
61. el Hasnaoui H, el Harrak M, Zientara S, et al. Serological and virological responses in mules and donkeys following inoculation with African horse sickness virus serotype 4. Archives of Virology (Supplement) 1998, 14:29-36.
62. Foote CE, Love DN, Gilkerson JR, et al. Detection of EHV-1 and EHV-4 DNA in unweaned Thoroughbred foals from vaccinated mares on a large stud farm. Equine Veterinary Journal 2004, 36:341-345.
63. Fortier G, Vidament M, DeCraene F, et al. The effect of GnRH antagonist on testosterone secretion, spermatogenesis and viral excretion in EVA-virus excreting stallions. Equine reproduction VIII. Proceedings of the Eighth International Symposium on Equine Reproduction Theriogenology 58 2002, 425-427. Elsevier, New York.
64. Fukunaga Y Equine viral arteritis: diagnostic and control measures. Journal of Equine Science 1994, 5:101-114.
65. Fukunaga Y, Wada R, Hirasawa K, et al. Effect of the modified Bucyrus strain of equine arteritis virus experimentally inoculated into horses. Bulletin of Equine Research Institute, Japan 1982, 19:97-101.
66. Fukunaga Y, Kumanimodo T, Kamada M, et al. Equine picornavirus: isolation of virus from the oral cavity of healthy horses. Bulletin of the Equine Research Institute 1983, 20:103-109.
67. Fukunaga Y, Wada R, Kanemaru T, et al. Immune potency of lyophilized, killed vaccine for equine viral arteritis and its protection against abortion in pregnant mares. Journal of Equine Veterinary Science 1996, 16:217-221.
68. Fukunaga Y, Wada R, Imagawa H, et al. Venereal infection of mares by equine arteritis virus and use of killed vaccine against the infection. Journal of Comparative Pathology 1997, 117:201-208.
69. Gerber H Clinical features, sequelae and epidemiology of equine influenza. Proceedings of the Second International Conference on Equine Infectious Diseases 1970, 63-80. Karger AG, Basel, .
70. Gibson JS, Slater JD, Awan AR, et al. Pathogenesis of equine herpesvirus-1 in specific pathogen-free foals: primary and secondary infections and reactivation. Archives of Virology 1992, 123:351-366.
71. Glass K, Wood JL, Mumford JA, et al. Modelling equine influenza 1: a stochastic model of within-yard epidemics. Epidemiology and Infection 2002, 128:491-502.
72. Gleeson LJ, Studdert MJ, Sullivan ND Pathogenicity and immunologic studies of equine adenovirus in specific-pathogen-free foals. American Journal of Veterinary Research 1978, 39:1636-1642.
73. Gomez-Villamandos JC, Sanchez C, Carrasco L, et al. Pathogenesis of African horse sickness: ultrastructural study of the capillaries in experimental infection. Journal of Comparative Pathology 1999, 121:101-116.
74. Gross DK, Hinchcliff KW, French PS, et al. Effect of moderate exercise on the severity of clinical signs associated with influenza virus infection in horses. Equine Veterinary Journal 1998, 30:489-497.
75. Gross DK, Morley PS, Hinchcliff KW, et al. Pulmonary ultrasonographic abnormalities associated with naturally occurring equine influenza virus infection in standardbred racehorses. Journal of Veterinary Internal Medicine 2004, 18:718-727.
76. Guillaume V, Lefeuvre A, Faure C, et al. Specific detection of Nipah virus using real-time RT-PCR (TaqMan). Journal of Virological Methods 2004, 120:229-237.
77. Guthrie AJ, Stevens KB, Bosman PP The circumstances surrounding the outbreak and spread of equine influenza in South Africa. Review of Science and Technology 1999, 18:179-185.
78. Halpin K, Young PL, Field HE, et al. Isolation of Hendra virus from pteropid bats: a natural reservoir of Hendra virus. Journal of General Virology 2000, 81:1927-1932.
79. Hamblin C, Graham SD, Anderson EC, et al. A competitive ELISA for the detection of group-specific antibodies to African horse sickness virus. Epidemiology and Infection 1990, 104:303-312.
80. Hamblin C, Mellor PS, Boned J The use of ELISA for the detection of African horse sickness viruses in Culicoides midges. Journal of Virological Methods 1991, 34:221-225.
81. Hamblin C, Mellor PS, Graham SD, et al. Antibodies in horses, mules and donkeys following monovalent vaccination against African horse sickness. Epidemiology and Infection 1991, 106:365-371.
82. Hamblin C, Mertens PP, Mellor PS, et al. A serogroup specific enzyme-linked immunosorbent assay for the detection and identification of African horse sickness viruses. Journal of Virological Methods 1991, 31:285-292.
83. Hamblin C, Salt JS, Mellor PS, et al. Donkeys as reservoirs of African horse sickness virus. Archives of Virology (Supplement) 1998, 14:37-47.
84. Hannant D, Mumford JA, Jessett DM Duration of circulating antibody and immunity following infection with equine influenza virus. Veterinary Record 1988, 122:125-128.
85. Hannant D, O'Neil T, Jessett DM, et al. Evidence for non-specific immunosuppression during the development of immune responses to equid herpesvirus-1. Equine Veterinary Journal Supplement 1991, 12:41-45.
86. Hannant D, Mumford JA Equine influenza. Virus Infections of Equines 1996, 285-293. Elsevier, Amsterdam. M.J. Studdert (Ed.).
87. Hedges JF, Balasuriya UB, MacLachlan NJ The open reading frame 3 of equine arteritis virus encodes an immunogenic glycosylated, integral membrane protein. Virology 1999, 264:92-98.
88. Heldens JG, Hannant D, Cullinane AA, et al. Clinical and virological evaluation of the efficacy of an inactivated EHV1 and EHV4 whole virus vaccine (Duvaxyn EHV1,4). Vaccination/challenge experiments in foals and pregnant mares. Vaccine 2001, 19:4307-4317.
89. Hinton TM, Crabb BS The novel picornavirus Equine rhinitis B virus contains a strong type II internal ribosomal entry site which functions similarly to that of Encephalomyocarditis virus. Journal of General Virology 2001, 82:2257-2269.
90. Hoffman AM, Viel L, Prescott JF, et al. Association of microbiologic flora with clinical, endoscopic, and pulmonary cytologic findings in foals with distal respiratory tract infection. American Journal of Veterinary Research 1993, 54:615-1622.
91. Holmes DF, Kemen MJ, Coggins L Equine rhinovirus infection - serological evidence of infection in selected United States horse populations. Proceedings of the Fourth International Conference on Equine Infectious Diseases, Lyon 1978, 315-319. Veterinary Publications, Princeton, NJ.
92. Holyoak GR, Little TV, McCollam WH, et al. Relationship between onset of puberty and establishment of persistent infection with equine arteritis virus in the experimentally infected colt. Journal of Comparative Pathology 1993, 109:29-46.
93. Hooper P, Zaki S, Daniels P, et al. Comparative pathology of the diseases caused by Hendra and Nipah viruses. Microbes and Infection 2001, 3:315-322.
94. House C, Mikiciuk PE, Berninger ML Laboratory diagnosis of African horse sickness: comparison of serological techniques and evaluation of storage methods of samples for virus isolation. Journal of Veterinary Diagnostic Investigation 1990, 2:44-50.
95. Howell PG The isolation and identification of further antigenic types of African horsesickness virus. Onderstepoort Journal of Veterinary Research 1962, 29:139-149.
96. Howell PG, Groenewald D, Visage CW, et al. The classification of seven serotypes of equine encephalosis virus and the prevalence of homologous antibody in horses in South Africa. Onderstepoort Journal of Veterinary Research 2002, 69:79-93.
97. Huang JA, Ficorilli N, Hartley CA, et al. Equine rhinitis B virus: a new serotype. Journal of General Virology 2001, 82:2641-2645.
98. Johnson B, Baldwin C, Timoney P, et al. Arteritis in equine fetuses aborted due to equine viral arteritis. Veterinary Pathology 1991, 28:248-250.
99. Klaey M, Sanchez-Higgins M, Leadon DP, et al. Field case study of equine rhinovirus 1 infection: clinical signs and clinicopathology. Equine Veterinary Journal 1998, 30:267-269.
100. Kleiboeker SB, Schommer SK, Johnson PJ, et al. Association of two newly recognized herpesviruses with interstitial pneumonia in donkeys ( Equus asinus). Journal of Veterinary Diagnostic Investigation 2002, 14:273-280.
101. Konishi SI, Harasawa R, Mochizuki M, et al. Studies on equine adenovirus. I. Characteristics of an adenovirus isolated from a thoroughbred colt with pneumonia. Nippon Juigaku Zasshi 1977, 39:117-125.
102. Kumar S, Tamura K, Jakobsen IB, Nei M MEGA2: molecular evolutionary genetics analysis software. Bioinformatics 2001, 17:1244-1245.
103. Kydd JH, Smith KC, Hannant D, et al. Distribution of equid herpesvirus-1 (EHV-1) in respiratory tract associated lymphoid tissue: implications for cellular immunity. Equine Veterinary Journal 1994, 26:470-473.
104. Kydd JH, Smith KC, Hannant D, et al. Distribution of equid herpesvirus-1 (EHV-1) in the respiratory tract of ponies: implications for vaccination strategies. Equine Veterinary Journal 1994, 26:466-469.
105. Kydd JH, Wattrang E, Hannant D Pre-infection frequencies of equine herpesvirus-1 specific, cytotoxic T lymphocytes correlate with protection against abortion following experimental infection of pregnant mares. Veterinary Immunology and Immunopathology 2003, 96:207-217.
106. Lai AC, Chambers TM, Holland RE, et al. Diverged evolution of recent equine-2 influenza (H3N8) viruses in the Western Hemisphere. Archives of Virology 2001, 146:1063-1074.
107. Li F, Drummer HE, Ficorilli N, et al. Identification of noncytopathic equine rhinovirus 1 as a cause of acute febrile respiratory disease in horses. Journal of Clinical Microbiology 1997, 35:937-943.
108. Livesay GJ, O'Neill T, Hannant D, et al. The outbreak of equine influenza (H3N8) in the United Kingdom in 1989: diagnostic use of an antigen capture ELISA. Veterinary Record 1993, 133:515-519.
109. Lord CC, Woolhouse ME, Rawlings P, et al. Simulation studies of African horse sickness and Culicoides imicola (Diptera: Ceratopogonidae). Journal of Medical Entomology 1996, 33:328-338.
110. Lord CC, Woolhouse ME, Barnard BJ Transmission and distribution of virus serotypes: African horse sickness in zebra. Epidemiology and Infection 1997, 118:43-50.
111. Lord CC, Woolhouse ME, Mellor PS Simulation studies of vaccination strategies in African horse sickness. Vaccine 1997, 15:519-524.
112. Lord CC, Woolhouse ME, Barnard BJ Transmission and distribution of African horse sickness virus serotypes in South African zebra. Archives of Virology (Supplement) 1998, 14:21-28.
113. Lord CC, Venter GJ, Mellor PS, et al. Transmission patterns of African horse sickness and equine encephalosis viruses in South African donkeys. Epidemiology and Infection 2002, 128:265-275.
114. Lubroth J African horse sickness and the epizootic in Spain 1987. Equine Practice 1988, 10:26-33.
115. Lunn DP, Holmes MA, Gibson J, et al. Haematological changes and equine lymphocyte subpopulation kinetics during primary infection and attempted re-infection of specific pathogen free foals with EHV-1. Equine Veterinary Journal 1991, 23:35-40.
116. Lunn DP, Hussey S, Sebing R, et al. Safety, efficacy, and immunogenicity of a modified-live equine influenza virus vaccine in ponies after induction of exercise-induced immunosuppression. Journal of the American Veterinary Medical Association 2001, 218:900-906.
117. Mackenzie JS, Field HE, Guyatt KJ Managing emerging diseases borne by fruit bats (flying foxes), with particular reference to henipaviruses and Australian bat lyssavirus. Journal of Applied Microbiology 2003, 94(Suppl):59S-69S.
118. MacLachlan NJ, Balasuriya UB, Hedges JF, et al. Serologic response of horses to the structural proteins of equine arteritis virus. Journal of Veterinary Diagnostic Investigation 1998, 10:229-236.
119. Matsumura T, Sugiura T, Imagawa H, et al. Epizootiological aspects of type 1 and type 4 equine herpesvirus infections among horse populations. Journal of Veterinary Medical Science 1992, 54:207-211.
120. Mayr A, Pette J 1st experiments concerning the vaccination of horses against rhino-pneumonia (viral abortion of mares) with a live vaccine from cell cultures. Bulletin of the Office of International Epizootics 1968, 70:133-140.
121. McChesney AE, England JJ, Whiteman CE, et al. Experimental transmission of equine adenovirus in Arabian and non-Arabian foals. American Journal of Veterinary Research 1974, 35:1015-1023.
122. McCollum WH Development of a modified virus strain and vaccine for equine viral arteritis. Journal of the American Veterinary Medical Association 1969, 155:318-322.
123. McCollum WH Studies of passive immunity in foals to equine viral arteritis. Veterinary Microbiology 1976, 1:45-54.
124. McCollum WH Responses of horses vaccinated with avirulent modified-live equine arteritis virus propagated in the E. Derm (NBL-6) cell line to nasal inoculation with virulent virus. American Journal of Veterinary Research 1986, 47:1931-1934.
125. McCollum WH, Timoney PJ Studies on the seroprevalence and frequency of equine rhinovirus-I and -II infection in normal horse urine. Proceedings of the Sixth International Conference on Equine Infectious Diseases, Cambridge 1992, 83-87. R&W Publications, Newmarket.
126. McCollum WH, Prickett ME, Bryans JT Temporal distribution of equine arteritis virus in respiratory mucosa, tissues and body fluids of horses infected by inhalation. Research in Veterinary Science 1971, 12:459-464.
127. McCollum WH, Little TV, Timoney PJ, et al. Resistance of castrated male horses to attempted establishment of the carrier state with equine arteritis virus. Journal of Comparative Pathology 1994, 111:383-388.
128. Meiswinkel R, Paweska JT Evidence for a new field Culicoides vector of African horse sickness in South Africa. Preventative Veterinary Medicine 2003, 60:243-253.
129. Mellor PS, Boorman J The transmission and geographical spread of African horse sickness and bluetongue viruses. Annals of Tropical Medicine and Parasitology 1995, 89:1-15.
130. Mellor PS, Wittmann EJ Bluetongue virus in the Mediterranean Basin 1998-2001. Veterinary Journal 2002, 164:20-37.
131. Mellor PS, Hamblin C African horse sickness. Veterinary Research 2004, 35:445-466.
132. Mellor PS, Hamblin C, Graham SD African horse sickness in Saudi Arabia. Veterinary Record 1990, 127:41-42.
133. Mellor PS, Rawlings P, Baylis M, et al. Effect of temperature on African horse sickness virus infection in Culicoides. Archives of Virology (Supplement) 1998, 14:155-163.
134. Moore BD, Balasuriya UB, Hedges JF, et al. Growth characteristics of a highly virulent, a moderately virulent, and an avirulent strain of equine arteritis virus in primary equine endothelial cells are predictive of their virulence to horses. Virology 2002, 298:39-44.
135. Moore BD, Balasuriya UB, Watson JL, et al. Virulent and avirulent strains of equine arteritis virus induce different quantities of TNF-alpha and other proinflammatory cytokines in alveolar and blood-derived equine macrophages. Virology 2003, 314:662-670.
136. Morley PS, Hanson LK, Bogdan JR, et al. The relationship between single radial hemolysis, hemagglutination inhibition, and virus neutralization assays used to detect antibodies specific for equine influenza viruses. Veterinary Microbiology 1995, 45:81-92.
137. Morley PS, Townsend HG, Bogdan JR, et al. Efficacy of a commercial vaccine for preventing disease caused by influenza virus infection in horses. Journal of the American Veterinary Medical Association 1999, 215:61-66.
138. Mumford JA Equine rhinovirus infections. Infectious Diseases of Livestock with Special Reference to South Africa 1994, vol. II:820-822. Oxford University Press, Oxford. J.A.W. Coetzer, G.R. Thomson, R.C. Tustin, N.P.J. Kriek (Eds.).
139. Mumford JA The equine influenza surveillance program. Advances in Veterinary Medicine 1999, 41:379-387.
140. Mumford JA, Thomson GR Studies on picornaviruses isolated from the respiratory tract of horses. Proceedings of the Fourth International Conference on Equine Infectious Diseases, Lyon 1978, 419-429. Veterinary Publications, Princeton, NJ.
141. Mumford JA, Wood J Establishing an acceptability threshold for equine influenza vaccines. Developments in Biological Standardization 1992, 79:137-146.
142. Mumford JA, Wood JM, Folkers C, et al. Protection against experimental infection with influenza virus A/equine/Miami/63 (H3N8) provided by inactivated whole virus vaccines containing homologous virus. Epidemiology and Infection 1988, 100:501-510.
143. Mumford JA, Jessett DM, Rollinson EA, et al. Duration of protective efficacy of equine influenza immunostimulating complex/tetanus vaccines. Veterinary Record 1994, 134:158-162.
144. Mumford JA, Wilson H, Hannant D, et al. Antigenicity and immunogenicity of equine influenza vaccines containing a Carbomer adjuvant. Epidemiology and Infection 1994, 112:421-437.
145. Mumford JA, Wood J, Jessett DM, et al. Efficacy of H3N8 influenza vaccines prepared from virus cultured in eggs or mammalian cells. Equine infectious diseases VII: Proceedings of the Seventh International Conference, Tokyo 1994, 342-343. R&W Publications, Newmarket.
146. Murray K, Selleck P, Hooper P, et al. A morbillivirus that caused fatal disease in horses and humans. Science 1995, 268:94-97.
147. Murray K, Dunn K, Murray G Hendra virus (equine morbillivirus): the outbreaks, the disease and lessons for preparedness. Proceedings of the Eighth International Conference on Equine Infectious Diseases, Dubai 1998, 3-10. R&W Publications, Newmarket.
148. Murray MJ, Eichorn ES, Dubovi EJ, et al. Equine herpesvirus type 2: prevalence and seroepidemiology in foals. Equine Veterinary Journal 1996, 28:432-436.
149. Murray MJ, del Piero F, Jeffrey SC, et al. Neonatal equine herpesvirus type 1 infection on a thoroughbred breeding farm. Journal of Veterinary Internal Medicine 1998, 12:36-41.
150. Naib ZM, Stewart JA, Dowdle WR, et al. Cytological features of viral respiratory tract infections. Acta Cytologica 1968, 12:162-171.
151. Newton JR, Verheyen K, Wood JL, et al. Equine influenza in the United Kingdom in 1998. Veterinary Record 1999, 145:449-452.
152. Newton JR, Lakhani KH, Wood JL, et al. Risk factors for equine influenza serum antibody titres in young thoroughbred racehorses given an inactivated vaccine. Preventive Veterinary Medicine 2000, 46:129-141.
153. Newton JR, Townsend HG, Wood JL, et al. Immunity to equine influenza: relationship of vaccine-induced antibody in young Thoroughbred racehorses to protection against field infection with influenza A/equine-2 viruses (H3N8). Equine Veterinary Journal 2000, 32:65-74.
154. Newton JR, Wood JL, Chanter N A case control study of factors and infections associated with clinically apparent respiratory disease in UK Thoroughbred racehorses. Preventative Veterinary Medicine 2003, 60:107-132.
155. Newton JR, Geraghty RJ, Castillo-Olivares J, et al. Evidence that use of an inactivated equine herpesvirus vaccine induces serum cytotoxicity affecting the equine arteritis virus neutralisation test. Vaccine 2004, 22:4117-4123.
156. Nordengrahn A, Rusvai M, Merza M, et al. Equine herpesvirus type 2 (EHV-2) as a predisposing factor for Rhodococcus equi pneumonia in foals: prevention of the bifactorial disease with EHV-2 immunostimulating complexes. Veterinary Microbiology 1996, 51:55-68.
157. Nugent J, Sinclair R, deVries AA, et al. Development and evaluation of ELISA procedures to detect antibodies against the major envelope protein (G(L)) of equine arteritis virus. Journal of Virological Methods 2000, 90:167-183.
158. Ostlund EN The equine herpesviruses. Veterinary Clinics of North American; Equine Practice 1993, 9:283-294.
159. Park AW, Wood JL, Newton JR, et al. Optimising vaccination strategies in equine influenza. Vaccine 2003, 21:2862-2870.
160. Park AW, Wood JL, Daly JM, et al. The effects of strain heterology on the epidemiology of equine influenza in a vaccinated population. Proceedings of the Royal Society of London. Series B, Biological Sciences 2004, 271:1547-1555.
161. Pascoe RR, Harden TJ, Spradbrow PB Letter: Experimental infection of a horse with an equine adenovirus. Australian Veterinary Journal 1974, 50:278-279.
162. Paweska JT, Venter GJ, Mellor PS Vector competence of South African Culicoides species for bluetongue virus serotype 1 (BTV-1) with special reference to the effect of temperature on the rate of virus replication in C. imicola and C. bolitinos. Medical and Veterinary Entomology 2002, 16:10-21.
163. Perryman LE, McGuire TC, Crawford TB Maintenance of foals with combined immunodeficiency: causes and control of secondary infections. American Journal of Veterinary Research 1978, 39:1043-1047.
164. Plummer G An equine respiratory virus with enterovirus properties. Nature 1962, 195:519-520.
165. Plummer G, Kerry JB Studies on an equine respiratory virus. Veterinary Record 1962, 74:967-970.
166. Powell DG, Burrows R, Goodridge D Respiratory viral infections among thoroughbred horses in training during 1972. Equine Veterinary Journal 1974, 6:19-24.
167. Prickett ME The pathology of disease caused by equine herpesvirus-1. Proceedings of the Second International Conference on Equine Infectious Diseases 1970, Karger, Basel.
168. Purse BV, Mellor PS, Rogers DJ, et al. Climate change and the recent emergence of bluetongue in Europe. National Review of Microbiology 2005, 3:71-181.
169. Rawlings P, Pro MJ, Pena I, et al. Spatial and seasonal distribution of Culicoides imicola in Iberia in relation to the transmission of African horse sickness virus. Medical and Veterinary Entomology 1997, 11:49-57.
170. Rees WA, Harkins JD, Woods WE, et al. Amantadine and equine influenza: pharmacology, pharmacokinetics and neurological effects in the horse. Equine Veterinary Journal 1997, 29:104-110.
171. Rees WA, Harkins JD, Lu M, et al. Pharmacokinetics and therapeutic efficacy of rimantadine in horses experimentally infected with influenza virus A2. American Journal of Veterinary Research 1999, 60:888-894.
172. Rodriguez JJ, Horvath CM Host evasion by emerging paramyxoviruses: Hendra virus and Nipah virus v proteins inhibit interferon signalling. Viral Immunology 2004, 17:210-219.
173. Roizmann B, Desrosiers RC, Fleckenstein B, et al. The family Herpesviridae: an update. The Herpesvirus Study Group of the International Committee on Taxonomy of Viruses. Archives of Virology 1992, 123:425-449.
174. Sailleau C, Moulay S, Cruciere C, et al. Detection of African horse sickness virus in the blood of experimentally infected horses: comparison of virus isolation and a PCR assay. Research in Veterinary Science 1997, 62:229-232.
175. Sailleau C, Hamblin C, Paweska JT, et al. Identification and differentiation of the nine African horse sickness virus serotypes by RT-PCR amplification of the serotype-specific genome segment 2. Journal of General Virology 2000, 81:831-837.
176. Scott JC, Dutta SK, Myrup AC In vivo harboring of equine herpesvirus-1 in leukocyte populations and subpopulations and their quantitation from experimentally infected ponies. American Journal of Veterinary Research 1983, 44:1344-1348.
177. Selvey LA, Wells RM, McCormack JG, et al. Infection of humans and horses by a newly described morbillivirus. Medical Journal of Australia 1995, 162:642-645.
178. Senne DA, Pearson JE, Carbrey EA Equine viral arteritis: a standard procedure for the virus neutralization test and comparison of results of a proficiency test performed at five laboratories. Proceedings of the United States Animal Health Association 1985, 89:29-34.
179. Sharma PC, Cullinane AA, Onions DE, et al. Diagnosis of equid herpesviruses -1 and -4 by polymerase chain reaction. Equine Veterinary Journal 1992, 24:20-25.
180. Shortridge KF, Chan WH, Guan Y Epidemiology of the equine influenza outbreak in China, 1993-94. Veterinary Record 1995, 136:160-161.
181. Slater JD, Borchers K, Thackray AM, et al. The trigeminal ganglion is a location for equine herpesvirus 1 latency and reactivation in the horse. Journal of General Virology 1994, 75:2007-2016.
182. Smith KC, Blunden AS, Whitwell KE, et al. A survey of equine abortion, stillbirth and neonatal death in the UK from 1988 to 1997. Equine Veterinary Journal 2003, 35:496-501.
183. Steck F, Hofer B, Schaeren B, et al. Equine rhinoviruses: new serotypes. Proceedings of the Fourth International Conference on Equine Infectious Diseases, Lyon 1978, 321-328. Veterinary Publications, Princeton, NJ.
184. Studdert MJ Antigenic homogeneity of equine adenoviruses. Australian Veterinary Journal 1978, 54:263-264.
185. Studdert MJ Equine adenovirus infections. Virus Infections of Vertebrates, vol. 6, Virus Infections of Equines 1996, 67-80. Elsevier Science, Amsterdam. M.J. Studdert (Ed.).
186. Studdert MJ, Gleeson LJ Isolation of equine rhinovirus type 1. Australian Veterinary Journal 1977, 53:452.
187. Studdert MJ, Gleeson LJ Isolation and characterisation of an equine rhinovirus. Zentralblatt für Veterinärmedizin B 1978, 25:225-237.
188. Studdert MJ, Blackney MH Isolation of an adenovirus antigenically distinct from equine adenovirus type 1 from diarrheic foal feces. American Journal of Veterinary Research 1982, 43:543-544.
189. Studdert MJ, Wilks CR, Coggins L Antigenic comparisons and serologic survey of equine adenoviruses. American Journal of Veterinary Research 1974, 35:693-699.
190. Telford EAR, Watson MS, McBride K, et al. The DNA sequence of equine herpesvirus-1. Virology 1992, 189:304-316.
191. Telford EAR, Watson MS, Perry J, et al. The DNA sequence of equine herpesvirus-4. Journal of General Virology 1998, 79:1197-1203.
192. The Royal Society Infectious Diseases of Livestock 2002, Royal Society, London.
193. Thompson DB, Spradborw PB, Studdert M Isolation of an adenovirus from an Arab foal with a combined immunodeficiency disease. Australian Veterinary Journal 1976, 52:435-437.
194. Thomson GR, Mumford JA, Campbell J, et al. Serological detection of equid herpesvirus 1 infections of the respiratory tract. Equine Veterinary Journal 1976, 8:58-65.
195. Timoney PJ Equine viral arteritis. Manual of Standards for Diagnostic Tests and Vaccines. Lists A and B Diseases of Mammals, Birds and Bees 2000, 582-594. Office International des Epizooties, Paris.
196. Timoney PJ, McCollum WH Equine viral arteritis - epidemiology and control. Journal of Equine Veterinary Science 1988, 8:54-59.
197. Timoney PJ, McCollum WH 1991 Equine viral arteritis: current clinical and economic significance. In: Proceedings of the thirty-sixth annual convention of the American Association of Equine Practitioners, Lexington, KY.
198. Timoney PJ, McCollom WH Equine viral arteritis in perspective in relation to international trade. Journal of Equine Veterinary Science 1993, 13:50-52.
199. Timoney PJ, McCollum WH Equine viral arteritis: further characterisation of the carrier state in stallions. Journal of Reproduction and Fertility Supplement 2000, 56:3-11.
200. Timoney PJ, McCollum WH, Murphy TW, et al. The carrier state in equine arteritis virus infection in the stallion with specific emphasis on the venereal mode of virus transmission. Journal of Reproduction and Fertility Supplement 1987, 35:95-102z.
201. Timoney PJ, McCollum WH, Roberts AW Current strategies for the control of equine viral arteritis. Proceedings of the United States Animal Health Association 1988, 92:211-218.
202. Timoney PJ, McCollum WH, Roberts AW, et al. Demonstration of the carrier state in naturally acquired equine arteritis virus infection in the stallion. Research in Veterinary Science 1986, 41:279-280.
203. Townsend HG, Penner SJ, Watts TC, et al. Efficacy of a cold-adapted, intranasal, equine influenza vaccine: challenge trials. Equine Veterinary Journal 2001, 33:637-643.
204. Varrasso A, Drummer HE, Huang JA, et al. Sequence conservation and antigenic variation of the structural proteins of equine rhinitis A virus. Journal of Virology 2001, 75:10550-10556.
205. Venter GJ, Paweska JT, Van Dijk AA, et al. Vector competence of Culicoides bolitinos and C. imicola for South African bluetongue virus serotypes 1, 3 and 4. Medical and Veterinary Entomology 1998, 12:378-385.
206. Westbury HA Hendra virus disease in horses. Review of Science and Technology 2000, 19:151-159.
207. Whitwell KE, Greet TR Collection and evaluation of tracheobronchial washes in the horse. Equine Veterinary Journal 1984, 16:499-508.
208. Whitlock RH, Dellers RW, Shively JN Adenoviral pneumonia in a foal. Cornell Veterinarian 1975, 65:393-401.
209. Wieringa R, de Vries AA, Raamsman MJ, et al. Characterization of two new structural glycoproteins, GP(3) and GP(4), of equine arteritis virus. Journal of Virology 2002, 76:10829-10840.
210. Wilks CR, Studdert MJ Isolation of an equine adenovirus. Australian Veterinary Journal 1972, 48:580-581.
211. Williams R, Du Plessis DH, Van Wyngaardt W Group-reactive ELISAs for detecting antibodies to African horsesickness and equine encephalosis viruses in horse, donkey, and zebra sera. Journal of Veterinary Diagnostic Investigation 1993, 5:3-7.
212. Williamson MM, Hooper PT, Selleck PW, et al. Transmission studies of Hendra virus (equine morbillivirus) in fruit bats, horses and cats. Australian Veterinary Journal 1998, 76:813-818.
213. Wood JL, Newton JR, Chanter N, et al. Association between respiratory disease and bacterial and viral infections in British racehorses. Journal of Clinical Microbiology 2005, 43:120-126.
214. Wood JM, Mumford J, Folkers C, et al. Studies with inactivated equine influenza vaccine. 1. Serological responses of ponies to graded doses of vaccine. Journal of Hygiene 1983, 90:371-384.
215. Wood JM, Schild GC, Folkers C, et al. The standardization of inactivated equine influenza vaccines by single-radial immunodiffusion. Journal of Biological Standardization 1983, 11:133-136.
216. Wood JM, Mumford J, Schild GC, et al. Single-radial-immunodiffusion potency tests of inactivated influenza vaccines for use in man and animals. Developments in Biological Standardization 1986, 64:169-176.
217. Wood JM, Mumford JA, Dunleavy U, et al. Single radial immunodiffusion potency tests for inactivated equine influenza vaccines. Proceedings of the 5th International Conference on Equine Infectious Diseases 1988, 74-79. University Press of Kentucky, Lexington, KY.
218. Yates P, Mumford JA Equine influenza vaccine efficacy: the significance of antigenic variation. Veterinary Microbiology 2000, 74:173-177.
219. Zhu XR, Wang CR, Shen BY, et al. Microbiological examination of horses with chronic obstructive pulmonary disease in Hexi district, Gansu province. Acta Veterinaria et Zootechnica Sinica 1989, 20:238-241.
220. Zientara S, Sailleau C, Moulay S, et al. Diagnosis and molecular epidemiology of the African horse sickness virus by the polymerase chain reaction and restriction patterns. Veterinary Research 1993, 24:385-395.